Cargando…

Whole-genome DNA hyper-methylation in iPSC-derived dopaminergic neurons from Parkinson’s disease patients

BACKGROUND: Parkinson’s disease (PD) is characterized by the loss of midbrain dopaminergic neurons (DAn). Previously, we described the presence of DNA hyper- and hypo-methylation alterations in induced pluripotent stem cells (iPSC)-derived DAn from PD patients using the Illumina 450K array which pro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fernández-Santiago, Rubén, Merkel, Angelika, Castellano, Giancarlo, Heath, Simon, Raya, Ángel, Tolosa, Eduard, Martí, María-José, Consiglio, Antonella, Ezquerra, Mario
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Short Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6651999/ https://www.ncbi.nlm.nih.gov/pubmed/31337434 http://dx.doi.org/10.1186/s13148-019-0701-6

Ejemplares similares

Aberrant epigenome in iPSC‐derived dopaminergic neurons from Parkinson's disease patients
por: Fernández‐Santiago, Rubén, et al.
Publicado: (2015)

Epigenetic Research of Neurodegenerative Disorders Using Patient iPSC-Based Models
por: Fernández-Santiago, Rubén, et al.
Publicado: (2016)

Mitochondrial Phenotypes in Parkinson’s Diseases—A Focus on Human iPSC-Derived Dopaminergic Neurons
por: Heger, Leonie M., et al.
Publicado: (2021)

Patient-Specific iPSC-Derived Astrocytes Contribute to Non-Cell-Autonomous Neurodegeneration in Parkinson's Disease
por: di Domenico, Angelique, et al.
Publicado: (2019)

CRISPR/Cas9-mediated generation of a tyrosine hydroxylase reporter iPSC line for live imaging and isolation of dopaminergic neurons
por: Calatayud, Carles, et al.
Publicado: (2019)

A pesticide and iPSC dopaminergic neuron screen identifies and classifies Parkinson-relevant pesticides
por: Paul, Kimberly C., et al.
Publicado: (2023)

Inborn errors of metabolism: Lessons from iPSC models
por: Escribá, Rubén, et al.
Publicado: (2021)

Preparation and Co‐Culture of iPSC‐Derived Dopaminergic Neurons and Astrocytes
por: de Rus Jacquet, Aurelie
Publicado: (2019)

Publisher Correction: A pesticide and iPSC dopaminergic neuron screen identifies and classifies Parkinson-relevant pesticides
por: Paul, Kimberly C., et al.
Publicado: (2023)

Parkinsonism Sac domain mutation in Synaptojanin-1 affects ciliary properties in iPSC-derived dopaminergic neurons
por: Rafiq, Nisha Mohd, et al.
Publicado: (2023)

Cytokine Profiling in Human iPSC-Derived Dopaminergic Neuronal and Microglial Cultures
por: Knappe, Evelyn, et al.
Publicado: (2023)

Biochemical Characteristics of iPSC-Derived Dopaminergic Neurons from N370S GBA Variant Carriers with and without Parkinson’s Disease
por: Grigor’eva, Elena V., et al.
Publicado: (2023)

Detailed Analysis of the Genetic and Epigenetic Signatures of iPSC-Derived Mesodiencephalic Dopaminergic Neurons
por: Roessler, Reinhard, et al.
Publicado: (2014)

Astrocytes Attenuate Mitochondrial Dysfunctions in Human Dopaminergic Neurons Derived from iPSC
por: Du, Fang, et al.
Publicado: (2018)

Identification of ASCL1 as a determinant for human iPSC-derived dopaminergic neurons
por: Earley, Aaron M., et al.
Publicado: (2021)

iPSC‐based modeling of THD recapitulates disease phenotypes and reveals neuronal malformation
por: Tristán‐Noguero, Alba, et al.
Publicado: (2023)

Mitochondrial Dysregulation and Impaired Autophagy in iPSC-Derived Dopaminergic Neurons of Multiple System Atrophy
por: Monzio Compagnoni, Giacomo, et al.
Publicado: (2018)

Negative Symptoms of Schizophrenia and Dopaminergic Transmission: Translational Models and Perspectives Opened by iPSC Techniques
por: Collo, Ginetta, et al.
Publicado: (2020)

Purification of functional human ES and iPSC-derived midbrain dopaminergic progenitors using LRTM1
por: Samata, Bumpei, et al.
Publicado: (2016)

Decreased Sirtuin Deacetylase Activity in LRRK2 G2019S iPSC-Derived Dopaminergic Neurons
por: Schwab, Andrew J., et al.
Publicado: (2017)

Corrigendum: Negative Symptoms of Schizophrenia and Dopaminergic Transmission: Translational Models and Perspectives Opened by iPSC Techniques
por: Collo, Ginetta, et al.
Publicado: (2021)

Human-Origin iPSC-Based Recellularization of Decellularized Whole Rat Livers
por: Acun, Aylin, et al.
Publicado: (2022)

Parkinson’s disease as a systemic pathology
por: Ezquerra, Mario, et al.
Publicado: (2019)

Establishment of an in vitro model for analyzing mitochondrial ultrastructure in PRKN-mutated patient iPSC-derived dopaminergic neurons
por: Yokota, Mutsumi, et al.
Publicado: (2021)

Microglia-Secreted Factors Enhance Dopaminergic Differentiation of Tissue- and iPSC-Derived Human Neural Stem Cells
por: Schmidt, Sissel Ida, et al.
Publicado: (2021)

Lysosomal and network alterations in human mucopolysaccharidosis type VII iPSC-derived neurons
por: Bayó-Puxan, Neus, et al.
Publicado: (2018)

Banking on iPSC- Is it Doable and is it Worthwhile
por: Solomon, Susan, et al.
Publicado: (2014)

Roadblocks in the Path of iPSC to the Clinic
por: Garreta, Elena, et al.
Publicado: (2018)

iPSC Bioprinting: Where are We at?
por: Romanazzo, Sara, et al.
Publicado: (2019)

Maturing iPSC-Derived Cardiomyocytes
por: Tang, Bor Luen
Publicado: (2020)

iPSC for modeling neurodegenerative disorders
por: Valadez-Barba, Valeria, et al.
Publicado: (2020)

iPSC-Derived Microglia as a Model to Study Inflammation in Idiopathic Parkinson’s Disease
por: Badanjak, Katja, et al.
Publicado: (2021)

Accumulation of mitochondrial 7S DNA in idiopathic and LRRK2 associated Parkinson's disease
por: Podlesniy, Petar, et al.
Publicado: (2019)

Pro-maturational Effects of Human iPSC-Derived Cortical Astrocytes upon iPSC-Derived Cortical Neurons
por: Hedegaard, Anne, et al.
Publicado: (2020)

Ropinirole and Pramipexole Promote Structural Plasticity in Human iPSC-Derived Dopaminergic Neurons via BDNF and mTOR Signaling
por: Collo, Ginetta, et al.
Publicado: (2018)

Identification of bioactive metabolites in human iPSC-derived dopaminergic neurons with PARK2 mutation: Altered mitochondrial and energy metabolism
por: Okarmus, Justyna, et al.
Publicado: (2021)

Generation of iPSC line from a Parkinson patient with PARK7 mutation and CRISPR-edited Gibco human episomal iPSC line to mimic PARK7 mutation
por: Mazza, Melissa Conti, et al.
Publicado: (2021)

The Small GTPase RAC1/CED-10 Is Essential in Maintaining Dopaminergic Neuron Function and Survival Against α-Synuclein-Induced Toxicity
por: Kim, Hanna, et al.
Publicado: (2018)

Correction to: The Small GTPase RAC1/CED-10 Is Essential in Maintaining Dopaminergic Neuron Function and Survival Against α-Synuclein-Induced Toxicity
por: Kim, Hanna, et al.
Publicado: (2018)

Optimizing maturity and dose of iPSC-derived dopamine progenitor cell therapy for Parkinson’s disease
por: Hiller, Benjamin M., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_memmrop4atnuv48bcmfeeakhul